Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 03/4/15 → 09/8/17 |
Funding
- AstraZeneca Pharmaceuticals LP: $19,093.75
A Phase II, Randomized, Open-Label,Multi-Center,Global Study of MEDI4736 Monotherapy, Tremelimumab Monotherapy,and MEDI4736 Combination with Tremelimumab in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head Neck...
- Keresztes, Roger (PI)
- Kudelka, Andrzej (CoPI)
Project: Research